RHOQ and cancer: As we demonstrated that the inhibition of mevalonate/farnesylation/RHOQ pathway selectively promotes the replication of the M1 virus in cancer cells, we proposed that blocking this pathway may substantially potentiate the therapeutic efficacy of the M1 virus.